Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity.

Molecular and Cellular Biology
B K MeyerG H Perdew

Abstract

Prior to ligand activation, the unactivated aryl hydrocarbon receptor (AhR) exists in a heterotetrameric 9S core complex consisting of the AhR ligand-binding subunit, a dimer of hsp90, and an unknown subunit. Here we report the purification of an approximately 38-kDa protein (p38) from COS-1 cell cytosol that is a member of this complex by coprecipitation with a FLAG-tagged AhR. Internal amino acid sequence information was obtained, and p38 was identified as the hepatitis B virus X-associated protein 2 (XAP2). The simian ortholog of XAP2 was cloned from a COS-1 cDNA library; it codes for a 330-amino-acid protein containing regions of homology to the immunophilins FKBP12 and FKBP52. A tetratricopeptide repeat (TPR) domain in the carboxy-terminal region of XAP2 was similar to the third and fourth TPR domains of human FKBP52 and the Saccharomyces cerevisiae transcriptional modulator SSN6, respectively. Polyclonal antibodies raised against XAP2 recognized p38 in the unliganded AhR complex in COS-1 and Hepa 1c1c7 cells. It was ubiquitously expressed in murine tissues at the protein and mRNA levels. It was not required for the assembly of an AhR-hsp90 complex in vitro. Additionally, XAP2 did not directly associate with hsp90 upon in ...Continue Reading

References

Jan 15, 1992·Biochemical and Biophysical Research Communications·G H Perdew
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K M BurbachC A Bradfield
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P RehbergerU Gehring
May 1, 1991·Trends in Biochemical Sciences·M Goebl, M Yanagida
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G GillilandH F Bunn
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Nov 15, 1981·Analytical Biochemistry·W WrayR Hancock
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Dec 8, 1995·The Journal of Biological Chemistry·B N FukunagaO Hankinson
Dec 1, 1995·Genes & Development·R L SmithA D Johnson
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·C RadanyiE E Baulieu
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·O Hankinson
Jul 1, 1995·Trends in Biochemical Sciences·J R LambP Hieter
Aug 11, 1994·Nucleic Acids Research·L A CarverC A Bradfield
Mar 1, 1994·Molecular and Cellular Biology·J L JohnsonD O Toft
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M DolwickC A Bradfield
Feb 16, 1996·The Journal of Biological Chemistry·B N Fukunaga, O Hankinson
May 31, 1996·The Journal of Biological Chemistry·K D DittmarW B Pratt
Jun 1, 1996·Biochemistry and Molecular Biology International·G H Perdew, C A Bradfield
Jan 1, 1996·Annual Review of Cell and Developmental Biology·J V Schmidt, C A Bradfield
Dec 1, 1996·Nucleic Acids Research·N KuzhandaiveluE Seto
Mar 1, 1997·Critical Reviews in Toxicology·J C Rowlands, J A Gustafsson
Apr 25, 1997·The Journal of Biological Chemistry·L A Carver, C A Bradfield

❮ Previous
Next ❯

Citations

Aug 19, 2008·FEBS Letters·Tony C LuuWilliam K Chan
Apr 21, 2009·FEBS Letters·Anna LaengerTheo Rein
Jun 21, 2014·International Journal of Molecular Sciences·Alexander EndlerFutoshi Shibasaki
Oct 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Hitoshi AshidaItsuko Fukuda
Dec 20, 2011·Biochemical and Biophysical Research Communications·Marumi OhnoMayumi Ishizuka
Jan 11, 2011·Biochimica Et Biophysica Acta·Masayuki EbinaHideaki Kikuchi
Sep 14, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Marianthi Georgitsi
Jun 24, 2010·Trends in Endocrinology and Metabolism : TEM·Harvinder S ChahalMárta Korbonits
Jul 6, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ghada AbdelhamidAyman O S El-Kadi
Jun 27, 2003·Microbiology and Immunology·Hirokazu OhataTakashi Okamoto
Feb 26, 2011·Clinical and Translational Science·Federica Guaraldi, Roberto Salvatori
Oct 22, 2010·Environmental Toxicology and Chemistry·Edward J PerkinsAlexandre Loguinov
Feb 18, 2014·Journal of Applied Toxicology : JAT·S Badal, R Delgoda
Nov 26, 2008·Biochemical Pharmacology·Kristen A Mitchell, Cornelis J Elferink
Nov 26, 2008·Biochemical Pharmacology·Jennifer L Head, B Paige Lawrence
Nov 6, 2008·Biochemical Pharmacology·Togo IkutaKaname Kawajiri
Sep 23, 2008·Biochemical Pharmacology·Simone Kobe de Oliveira, Albert Smolenski
Apr 6, 2004·Biochemical and Biophysical Research Communications·Togo IkutaKaname Kawajiri
Aug 24, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Shin NishiumiHitoshi Ashida
Apr 30, 2015·Archives of Gynecology and Obstetrics·Vincenza SofoMauricio Simões Abrão
Feb 27, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sonia MohintaAvery August
Aug 17, 2011·Free Radical Biology & Medicine·Issa E A Amara, Ayman O S El-Kadi
Aug 5, 2011·Journal of Cardiovascular Disease Research·Nan Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.